Cnb Bank Edwards Lifesciences Corp Transaction History

Cnb Bank

$213 Million
Q4 2024

A detailed history of Cnb Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cnb Bank holds 89 shares of EW stock, worth $6,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 987 90.98%

Holding current value

$6,144

Previous $65,000 90.77%

% of portfolio

0.0%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$64.54 - $75.92 $57,956 - $68,176	-898 Reduced 90.98%	89 $6,000
Q3 2024 Oct 18, 2024	SELL	$59.7 - $93.78 $63,938 - $100,438	-1,071 Reduced 52.04%	987 $65,000
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $21,665 - $24,237	-257 Reduced 11.1%	2,058 $190,000
Q1 2024 May 02, 2024	SELL	$72.54 - $95.56 $11,026 - $14,525	-152 Reduced 6.16%	2,315 $221,000
Q4 2023 Jan 31, 2024	SELL	$61.71 - $77.76 $30,114 - $37,946	-488 Reduced 16.51%	2,467 $188,000
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $153,039 - $206,276	-2,209 Reduced 42.78%	2,955 $204,000
Q2 2023 Aug 08, 2023	SELL	$81.41 - $94.33 $8,059 - $9,338	-99 Reduced 1.88%	5,164 $487,000
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $28,218 - $32,113	380 Added 7.78%	5,263 $435,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $28,822 - $36,899	422 Added 9.46%	4,883 $364,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $27,511 - $35,834	334 Added 8.09%	4,461 $368,000
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $12,975 - $19,240	150 Added 3.77%	4,127 $392,000
Q1 2022 Apr 13, 2022	SELL	$101.96 - $128.34 $18,250 - $22,972	-179 Reduced 4.31%	3,977 $469,000
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $26,273 - $32,277	247 Added 6.32%	4,156 $538,000
Q3 2021 Nov 02, 2021	BUY	$102.91 - $122.75 $27,579 - $32,897	268 Added 7.36%	3,909 $442,000
Q2 2021 Jul 29, 2021	BUY	$83.84 - $104.76 $13,414 - $16,761	160 Added 4.6%	3,641 $376,000
Q1 2021 May 03, 2021	BUY	$78.68 - $90.67 $42,723 - $49,233	543 Added 18.48%	3,481 $291,000
Q4 2020 Jan 27, 2021	BUY	$71.69 - $91.23 $29,177 - $37,130	407 Added 16.08%	2,938 $268,000
Q3 2020 Oct 26, 2020	SELL	$67.19 - $87.44 $17,536 - $22,821	-261 Reduced 9.35%	2,531 $202,000
Q2 2020 Jul 14, 2020	BUY	$57.54 - $76.95 $109,958 - $147,051	1,911 Added 216.91%	2,792 $193,000
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $4,507 - $6,966	86 Added 10.82%	881 $166,000
Q4 2019 Jan 27, 2020	BUY	$71.7 - $82.09 $1,147 - $1,313	16 Added 2.05%	795 $185,000
Q3 2019 Nov 04, 2019	BUY	$61.55 - $75.43 $36,314 - $44,503	590 Added 312.17%	779 $171,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $10,534 - $12,173	189 New	189 $35,000
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $3,495 - $4,460	-94 Closed	0 $0
Q4 2017 Feb 20, 2018	BUY	$33.79 - $39.39 $3,176 - $3,702	94	94 $11,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

462M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account